Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen-Rich Saline Reduces Brain Blood Vessel Spasms After Stroke in Rats

Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats

Research hubs: Brain & Nervous System · Cardiovascular System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats
Evidence type
Animal study (rat)
Authors
Yuan Hong, Songxue Guo, Sheng Chen, Chongran Sun, Jianmin Zhang, Xue-Jun Sun
Journal
Journal of Neuroscience Research
Year
2012
Study Type
Rat
Delivery
Saline (Dissolved)
Dose
5 ml/kg hydrogen-rich saline injected intraperitoneally immediately and at 24 hr after injury
Duration
2 days
Outcome
Positive
Peer Reviewed
Yes
Cited by
32 (OpenAlex, as of November 2026)
Country
China

TL;DR

Treating rats with hydrogen-rich saline improved brain health and reduced blood vessel narrowing after a type of stroke caused by bleeding in the brain.

Key Finding

Hydrogen-rich saline treatment significantly improved neurological outcomes and reduced basilar artery vasospasm in rats with experimentally induced subarachnoid hemorrhage, with benefits appearing to stem from reduced oxidative stress and inflammation.

Summary

Researchers studied whether hydrogen-rich saline could help prevent cerebral vasospasm (abnormal narrowing of blood vessels in the brain) that occurs after subarachnoid hemorrhage (bleeding in the space around the brain). In rats with experimentally induced brain bleeding, hydrogen-rich saline treatment improved neurological function and reduced blood vessel narrowing. The treatment appeared to work by reducing harmful molecules called free radicals and decreasing inflammation in blood vessels.

Practical Takeaway

While this rat study suggests hydrogen may help protect against blood vessel complications after brain bleeding, these results cannot yet be applied to humans. Much more research, including human clinical trials, would be needed before hydrogen therapy could be considered a treatment option for this serious condition.

Abstract (excerpt)

AbstractCerebral vasospasm (CV) remains a common and devastating complication in patients with subarachnoid hemorrhage (SAH). Despite its clinical significance and extensive research, the underlying pathogenesis and therapeutic perspectives of CV remain incompletely understood. Recently, it has…

Read the full abstract on PubMed